TIAA CREF INVESTMENT MANAGEMENT LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 64 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q1 2017$62,000
-38.0%
50,867
+0.0%
0.00%
Q4 2016$100,000
-45.4%
50,862
-2.2%
0.00%
Q3 2016$183,000
-1.6%
52,008
-0.0%
0.00%
Q2 2016$186,000
-2.6%
52,009
+31.4%
0.00%
Q1 2016$191,000
-18.0%
39,5850.0%0.00%
Q4 2015$233,000
-0.9%
39,5850.0%0.00%
Q3 2015$235,000
-85.6%
39,585
-67.0%
0.00%
-100.0%
Q2 2015$1,634,000
+127.9%
120,067
+114.7%
0.00%
Q1 2015$717,000
+218.7%
55,934
+155.1%
0.00%
Q4 2014$225,00021,9230.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,492,975$3,597,974,0001.05%
&PARTNERS 51,961$42,0000.06%
Glassman Wealth Services 72,366$58,0000.02%
Sigma Planning Corp 385,737$309,0000.02%
HBK Sorce Advisory LLC 100,000$80,0000.01%
Fore Capital, LLC 56,300$45,0000.01%
WealthTrust Axiom LLC 17,320$13,0000.01%
B. Riley Wealth Management, Inc. 40,800$33,0000.01%
Semmax Financial Advisors Inc. 7,290$6,0000.00%
Ausdal Financial Partners, Inc. 10,025$9,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders